Equinor ASA (LON:0A7F)
24.32
+0.29 (1.22%)
At close: Nov 7, 2025
Equinor ASA Revenue
Equinor ASA had revenue of $26.02B USD in the quarter ending September 30, 2025, with 2.36% growth. This brings the company's revenue in the last twelve months to $107.07B, up 2.15% year-over-year. In the year 2024, Equinor ASA had annual revenue of $102.50B, down -4.07%.
Revenue (ttm)
$107.07B
Revenue Growth
+2.15%
P/S Ratio
0.58
Revenue / Employee
$4.35M
Employees
24,641
Market Cap
46.17B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 102.50B | -4.35B | -4.07% |
| Dec 31, 2023 | 106.85B | -42.16B | -28.29% |
| Dec 31, 2022 | 149.00B | 58.34B | 64.35% |
| Dec 31, 2021 | 90.67B | 44.90B | 98.11% |
| Dec 31, 2020 | 45.77B | -17.15B | -27.25% |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |